Related references
Note: Only part of the references are listed.First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
Chiara Testa et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
Mateusz Kciuk et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Characteristics of the cancer stem cell niche and therapeutic strategies
Feng Ju et al.
STEM CELL RESEARCH & THERAPY (2022)
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
Rui Sun et al.
CANCER AND METASTASIS REVIEWS (2022)
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
Iris C. Salaroglio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)
Hang Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka et al.
DRUG RESISTANCE UPDATES (2021)
Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells
Diana Tavares-Valente et al.
PHARMACEUTICS (2021)
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
Rui Han et al.
SCIENTIFIC REPORTS (2021)
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors
Jason Goebel et al.
CANCER DRUG RESISTANCE (2021)
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor
Chiara Riganti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells
Elisabetta Teodori et al.
MOLECULES (2020)
Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII
Gaia Giuntini et al.
CANCERS (2020)
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Dimas Carolina Belisario et al.
CELLS (2020)
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators
Silvia Dei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers
Elisabetta Teodori et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance
Ana Podolski-Renic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Deepali Waghray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo
Bettina von Neubeck et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018)
Alessio Nocentini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Claudiu T. Supuran
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma
Iris C. Salaroglio et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
Paul C. McDonald et al.
METABOLITES (2018)
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Prashant Joshi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Carbonic anhydrase XII functions in health and disease
Abdul Waheed et al.
GENE (2017)
9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein
Katja Stefan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers
Elisabetta Teodori et al.
CHEMMEDCHEM (2017)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
Kulthida Vaeteewoottacharn et al.
TUMOR BIOLOGY (2016)
Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin
Leman Yalcintepe et al.
ONCOLOGY LETTERS (2016)
P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors
Joanna Kopecka et al.
ONCOTARGET (2016)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
Joanna Kopecka et al.
ONCOTARGET (2015)
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters
Silvia Dei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition
Joanna Kopecka et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Antitumor Efficacy of a Monoclonal Antibody That Inhibits the Activity of Cancer-Associated Carbonic Anhydrase XII
Gabor Gondi et al.
CANCER RESEARCH (2013)
Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)
Simona Maria Monti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Sulfocounnarins (1,2-Benzoxathiine-2,2-dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases
Kaspars Tars et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
A. Palmeira et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: Further restriction of molecular flexibility maintains high potency and efficacy
Cecilia Martelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
ABC Proteins Protect the Human Body and Maintain Optimal Health
Kazumitsu Ueda
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
P-glycoprotein Inhibition: The Past, the Present and the Future
Richard A.J. Darby et al.
CURRENT DRUG METABOLISM (2011)
Immunoaffinity Enrichment and Liquid Chromatography-Selected Reaction Monitoring Mass Spectrometry for Quantitation of Carbonic Anhydrase 12 in Cultured Renal Carcinoma Cells
Agnes Rafalko et al.
ANALYTICAL CHEMISTRY (2010)
Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins
Alfonso Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Structure-Activity Relationships Studies in a Series of N,N-Bis(alkanol)amine Aryl Esters as P-Glycoprotein (Pgp) Dependent Multidrug Resistance (MDR) Inhibitors
Cecilia Martelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Johanna Chiche et al.
CANCER RESEARCH (2009)
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Alfonso Maresca et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
High-Resolution Mass Spectrometers
Alan G. Marshall et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (2008)
P-glycoprotein kinetics measured in plasma membrane vesicles and living cells
Paeivi Aeaenismaa et al.
BIOCHEMISTRY (2007)
Saccharin inhibits carbonic anhydrases: Possible explanation for its unpleasant metallic aftertaste
Karen Koehler et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
P. Hynninen et al.
HISTOPATHOLOGY (2006)
Human multidrug resistance ABCB and ABCG transporters:: Participation in a chemoimmunity defense system
Balazs Sarkadi et al.
PHYSIOLOGICAL REVIEWS (2006)
Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models
E Teodori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin
E Miraglia et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Predicting drug sensitivity and resistance:: Profiling ABC transporter genes in cancer cells
G Szakács et al.
CANCER CELL (2004)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
